Publication date: Mar 01, 2025
The BCG vaccine is effective in preventing severe tuberculosis infections in infants and young children, and it is commonly administered in Japan to those aged between 5 to 8 months. Although the incidence of adverse reactions is low, disseminated lymphadenitis and osteomyelitis have been reported as potential side effects. We encountered a case of BCG osteomyelitis with typical imaging findings. Provided the clinical presentation and imaging features are recognized, it is possible to diagnose BCG osteomyelitis definitively and exclude a number of possible differential diagnoses.
| Concepts | Keywords |
|---|---|
| Infants | Adverse reactions |
| Japan | BCG osteomyelitis |
| Osteomyelitis | BCG vaccine |
| Tuberculosis | Pediatrics |
| Vaccine |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | BCG vaccine |
| disease | MESH | osteomyelitis |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | infections |
| disease | MESH | lymphadenitis |